BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11390537)

  • 1. Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer.
    Meyer P; James VJ
    J Natl Cancer Inst; 2001 Jun; 93(11):873-5. PubMed ID: 11390537
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
    Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
    [No Abstract]   [Full Text] [Related]  

  • 3. Human breast cancer specimens: diffraction-enhanced imaging with histologic correlation--improved conspicuity of lesion detail compared with digital radiography.
    Pisano ED; Johnston RE; Chapman D; Geradts J; Iacocca MV; Livasy CA; Washburn DB; Sayers DE; Zhong Z; Kiss MZ; Thomlinson WC
    Radiology; 2000 Mar; 214(3):895-901. PubMed ID: 10715065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-stage breast cancer rates rise sharply as invasive breast cancer levels off.
    Oncology (Williston Park); 2005 Aug; 19(9):1176. PubMed ID: 16404785
    [No Abstract]   [Full Text] [Related]  

  • 5. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS; Apple SK
    Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on preoperative staging with breast MRI.
    Hollingsworth AB
    J Am Coll Surg; 2004 Jul; 199(1):173-4. PubMed ID: 15217651
    [No Abstract]   [Full Text] [Related]  

  • 7. [Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].
    Calabrese L
    Acta Biomed Ateneo Parmense; 1998; 69(3-4):113-21. PubMed ID: 10503071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of noninvasive (in situ) breast cancer.
    Silverstein MJ
    Adv Surg; 2000; 34():17-41. PubMed ID: 10997214
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathology of breast cancer and the role of the histopathology laboratory.
    Hanby AM
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):234-9. PubMed ID: 15997917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
    Houssami N; Ambrogetti D; Marinovich ML; Bianchi S; Macaskill P; Vezzosi V; Mamounas EP; Ciatto S
    Ann Surg Oncol; 2011 May; 18(5):1364-71. PubMed ID: 21107741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
    Nye L; Rademaker A; Gradishar WJ
    Clin Breast Cancer; 2017 Jul; 17(4):e185-e189. PubMed ID: 28185739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lobular neoplasia].
    Sigal-Zafrani B; Vincent-Salomon A; Penault-Llorca F; Sastre-Garau X
    Ann Pathol; 2003 Dec; 23(6):547-53. PubMed ID: 15094592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differences between clinical response and pathologic response of breast cancer after neoadjuvant chemotherapy].
    Zheng S; Zhang BL; Zhang RZ; Yang JL; Zou SM; Xue LY; Luo W; Yuan YL; Lü N
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):734-8. PubMed ID: 21215162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratifying the outcome after neoadjuvant treatment using pathological response classification by the Japanese Breast Cancer Society.
    Mukai H; Arihiro K; Shimizu C; Masuda N; Miyagi Y; Yamaguchi T; Yoshida T
    Breast Cancer; 2016 Jan; 23(1):73-77. PubMed ID: 26423822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases.
    Ross DS; Hoda SA
    Am J Surg Pathol; 2011 May; 35(5):750-6. PubMed ID: 21415700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of routine cavity shave margins on breast cancer re-excision rates.
    Kobbermann A; Unzeitig A; Xie XJ; Yan J; Euhus D; Peng Y; Sarode V; Moldrem A; Marilyn Leitch A; Andrews V; Stallings C; Rao R
    Ann Surg Oncol; 2011 May; 18(5):1349-55. PubMed ID: 21046260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is (18)F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?
    Orevi M; Freedman N; Tahover E; Uziely B; Chisin R; Peretz T; Klein M
    Acta Oncol; 2016; 55(2):244-7. PubMed ID: 26106853
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histological features of breast cancer as predictive factors for chemotherapy].
    Horii R; Akiyama F
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():160-4. PubMed ID: 17679197
    [No Abstract]   [Full Text] [Related]  

  • 20. The dilemma of lobular carcinoma in situ at percutaneous biopsy: to excise or to monitor.
    Gabriel H
    AJR Am J Roentgenol; 1999 Aug; 173(2):300-2. PubMed ID: 10430123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.